Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Hepatitis E serology

PreclinicalBiologic

HHospices Civils de Lyon

Hepatitis E serology is one of 2 biologic programs targeting Hepatitis E Virus Infection. It is currently in Preclinical.

1

Indications

1

Total Trials

0

Active Trials

1

Competitors

Pipeline

Status by Indication[3][1]

Indication

Hepatitis E Virus InfectionActive, not recruiting

Hepatitis E Virus InfectionPreclinical

Active, not recruiting

Competition

Competitive Landscape

2 competitors in Hepatitis E Virus Infection

#DrugCompanyPhaseTrials

Virazole

CConrado Roberto Hoffmann Filho

Hepatitis E serology

HHospices Civils de Lyon

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Hepatitis E Virus Infection1 trial

Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence Study

Unknown status·HHospices Civils de Lyon·N/A·NCT02809885·226 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Hepatitis E serology. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Hepatitis E serology compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Hepatitis E serology. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Hospices Civils de Lyon company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: HHospices Civils de Lyon

Related News